Pain Management Smartphone Application for Patients With Stage III-IV Head and Neck Cancer Undergoing Radiation Therapy
Head and Neck Cancer, Pain, Lung Cancer
About this trial
This is an interventional health services research trial for Head and Neck Cancer focused on measuring smartphone, application, pain management
Eligibility Criteria
Inclusion Criteria:
- Radiation oncology patients undergoing 5-7 weeks of definitive radiation therapy for head and neck, esophageal or lung cancer.
- Ability to understand and the willingness to use the PMSA on the patient's personal smartphone
- Displays ability to use and understand the PMSA as evidenced by successful response to alarm and successful entries while monitored by the principal investigator (PI)
- Willing and able to provide informed consent and fill out demographic, disease, and pain assessment questionnaires
- English speaking
Exclusion Criteria:
- Radiation oncology patients undergoing palliative courses of radiation
- Patients who do not own smartphones
- Patients who are unable to successfully respond to the PMSA alarm and properly enter their data
- Patients who are unable to eat and drink normally
- Patients who are unable to validate their understanding of the pain scale
Sites / Locations
- Vanderbilt-Ingram Cancer Center
Arms of the Study
Arm 1
Experimental
Health Services Research (PMSA)
Patients/caregivers are instructed to download the PMSA and are demonstrated how to properly use the application. Beginning on the first day of radiation therapy (day 1), patients are instructed to use the PMSA for the duration of their radiation therapy (up to day 50). The patient will fill out a satisfaction questionnaire at the completion of their treatment (Questionnaire administration). The timing of use may change depending on the availability of the app. The use of the app is classified as the "telephone-based intervention" per NCI.